Aug. 20, 2020 Patent granted for enhancement of adipose-derived mesenchymal stem cells by statin PLGA nanoparticles for inflammatory diseases in the US

A local agent reported on July 29, 2020 that a patent to enhance the function of adipose-derived stem cells by adding statin PLGA nanoparticles was evaluated and was granted in the United States on July 29, 2020.

This makes it easy for us to develop our business in the United States using our technology.